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CLINICAL INVESTIGATION
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Comparative effects of acetate and bicarbonate hemodialysis on left
ventricular function. To assess the comparative effects of hemodialysis
with acetate versus bicarbonate base on left ventricular systolic func-
tion, we performed M-mode echocardiography on 36 patients prior to
and immediately following 4-hr maintenance hemodialysis. Patients
were initially dialyzed against either sodium acetate or sodium bi-
carbonate and I week later were dialyzed against the alternate base.
The mean velocity of circumferential fiber shortening (mean Vcf,
circumferences/s) was used to assess left ventricular systolic function.
In patients with normal pre-dialysis mean Vcfhemodialysis with acetate
produced no significant change in mean Vet, whereas hemodialysis with
bicarbonate produced a significant increase in mean Vcf. In patients
with low pre-dialysis mean Vcf hemodialysis with either base produced
a significant increase in mean Vcf. Mean Vcf values obtained after
hemodialysis with bicarbonate were significantly higher than those
obtained after hemodialysis with acetate, both in patients with normal
and low pre-hemodialysis mean Vcf. We conclude that hemodialysis
with bicarbonate produces a comparatively greater improvement in left
ventricular systolic function than hemodialysis with acetate.
Effets comparatifs de l'hémodialyse en acetate ou en bicarbonate sur Ia
fonction ventriculaire gauche. Afin de préciser les effets compares de
l'hémodialyse en base acetate par rapport a une base bicarbonate sur Ia
fonction systolique ventriculaire gauche, nous avons fait des
échocardiographies en mode M chez 36 malades avant et
immédiatement après une hemodialyse de quatre heures. Les malades
étaient d'abord dialyses contre de l'acétate de sodium ou contre du
bicarbonate de sodium et une semaine plus tard étaient dialyses contre
l'autre base. La vitesse moyenne de raccourcissement des fibres
circonférentielles (Vcf moyenne, circonférences/s) a été utilisée pour
aprécier Ia fonction systolique ventriculaire gauche. Chez les malades
ayant une Vcf moyenne pre-dialytique normale, l'hémodialyse avec
acetate n'a entrainé aucune modification significative de Vcf moyenne,
tandis que l'hemodialyse avec bicarbonate a augmenté significative-
ment la Vcf moyenne. Chez les malades ayant une faible Vcf moyenne
avant dialyse, l'hémodialyse avec une des deux bases a significative-
ment accru Ia Vcf moyenne. Les valeurs de Vcf moyenne obtenues
après hémodialyse avec bicarbonate étaient significativement plus
hautes que celles obtenues après hémodialyse avec acetate, chez les
malades avec Vcf moyenne normale ou basse avant dialyse. Nous
concluons que l'hemodialyse avec bicarbonate entraIne une
amelioration comparativement plus grande de Ia fonction systolique
ventriculaire gauche que l'hCmodialyse avec acetate.
Sodium acetate was introduced as a base for hemodialysis by
Mion et a! in 1964 [1]. Since then, it has replaced sodium
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bicarbonate as the most commonly used source of fixed base in
hemodialysis solutions. Data concerning the effect of acetate
and bicarbonate on myocardial performance are conflicting.
Animal studies suggest that sodium acetate and sodium bi-
carbonate both produce a myocardial depressant effect [2—4],
whereas studies in humans suggest a variable improvement in
left ventricular systolic performance resulting from hemodialy-
sis with either base [5—7]. Recent publications have demon-
strated that the hemodynamic response to hemodialysis is
related closely to the pre-dialysis state of left ventricular
systolic function [8, 9]. The objective of this study was to
examine the comparative effects of hemodialysis with acetate
and bicarbonate bases on left ventricular systolic function in
consideration of these observations.
Methods
Patient selection
The study population consisted of clinically stable patients
with chronic renal failure undergoing chronic maintenance
hemodialysis. Subjects were excluded from the study if at the
time of the study they demonstrated definite heart failure [10],
valvular heart disease, congenital heart disease, a moderate-to-
large pericardial effusion [11], or any acute illness. Patients on
beta-blocking agents and those with left ventricular regional
wall motion abnormalities (identified by two-dimensional echo-
cardiography or radionuclide left ventriculography) were also
excluded. Informed consent was obtained from each patient.
Protocol
All patients were hemodialyzed for 4 hr using hollow fiber
dialyzers. Each patient was hemodialyzed initially against their
usual dialysate base (acetate or bicarbonate). One week later,
on the third subsequent dialysis, each patient was dialyzed
against the alternate base. Body weight, blood pressure, heart
rate, and echocardiographic data were obtained just before and
immediately following each hemodialysis session. M-mode
echocardiography was performed using an ultrasonography
(Echo IV, Electronics for Medicine/Honeywell, Inc., Min-
neapolis, Minnesota, USA) with a 2.25 MHz transducer.
Echocardiograms were obtained with the patient in the semi-
recumbent and left lateral positions from an echocardiographic
window located in the third or fourth intercostal space at the left
sternal border. M-mode sweeps were used to ensure reproduc-
768
Acetate versus bicarbonate on ventricular function 769
ible ultrasound beam positioning. Echocardiographic data were
analyzed according to the recommendations of the American
Society of Echocardiography [12]. Basic echocardiographic
measurements and the ranges of normal values used were as
follows: left ventricular internal dimension in diastole (LVIDd,
3.8 to 5.6 cm), the left ventricular internal dimension in systole
(LVID, cm), the interventricular septal thickness in diastole
(0.6 to 1 .1 cm), the left ventricular posterior wall thickness in
diastole (0.6 to 1.1 cm), left atrial size (1.9 to 4.0 cm), and the
right ventricular internal dimension (RVID, 0.7 to 2.3 cm).
M-mode echocardiographic aortic valve motion was used to
measure left ventricular ejection time (LVET). The mean
velocity of left ventricular circumferential fiber shortening
(mean Vcf, 1.02 to 1.94 circumferences!s) was calculated using
the following formula [13]:
LVIDd - LVIDSMean Vcf = ______________
LVID x LVET
Blood pressure was obtained using a cuff sphygmomanometer
from the arm that did not contain the AV fistula. Mean systemic
arterial pressure (normal range, 70 to 105 mm Hg) was calcu-
lated by adding one-third of the pulse pressure to the diastolic
blood pressure
Echocardiographers and echocardiogram interpreters were
unaware of which base was being used during any given dialysis
session.
Statistical analysis
Because of the large number of paired comparisons required,
we performed a one-way analysis of variance for matched data
to determine whether differences existed across strata for a
given variable [14]. If the analysis of variance was significant for
a given variable (P < 0.05), then comparisons were performed
on relevant pairs using Student's t test for paired data. To
obtain an overall level of significance less than 0.05, a
Bonferonni adjustment [14] was performed by dividing less than
0.05 by four (the number of paired comparisons for each
variable). Thus, P less than 0.01 was necessary for any given
comparison to achieve an overall significance level of less than
0.05.
Results
Patient characteristics
The study population consisted of 36 patients, 22 males and
14 females. Their mean age SD of the mean was 53 8 years.
Twenty-three subjects had a history of systemic hypertension,
five had coronary artery disease (definite angina pectoris or
prior myocardial infarction documented by cardiac enzyme
elevation and/or electrocardiography), and nine had a history of
congenital heart failure. Four patients were receiving digoxin at
the time of the study. Two patients became hypotensive shortly
after the initiation of acetate hemodialysis and were excluded
from the study.
Factors relating to hemodialysis
Twenty-six patients were dialyzed routinely with acetate
base and ten were dialyzed routinely with bicarbonate base. All
hemodialysis sessions were 4 hr in duration. Table 1 shows the
mean ultrafiltration rates, mean dialysis solution component
Table 1. Factors relating to hemodialysis
Factor
Acetate
hemodialysis
N = 36
Bicarbonate
hemodialysis
N= 36
Mean ultrafiltration rate,
mI/mm 10.4 0.3k 10.6 0.3
Dialysis solution components,
average values in mEqiliter
Sodium 142 139
Potassium 1.5 1.5
Calcium 3.6 3.5
Magnesium 1.2 1.0
Chloride 113 105
Glucose, mgldl 98 200
Bicarbonate — 39
Acetate 35 —
Acetic acid — 4
Pre-dialysis serum electrolyte
concentration ranges
Sodium, mEqiliter 132 to 144 131 to 145
Potassium, inEqilizer 4.2 to 5.4 4.0 to 4.5
Calcium, mg/dl 8.4 to 10.6 8.6 to 10.6
a The values shown are SEM.
concentrations, and ranges of serum electrolyte concentrations
during acetate and bicarbonate dialysis.
Effect of hemodialysis on clinical and echocardiographic
variables
Clinical and echocardiographic data were compared in four
ways. First pre-dialysis data from the acetate and bicarbonate
group were compared (A versus C) to determine if differences
existed in the starting point for any variable measured. Second,
pre-dialysis data were compared with post-dialysis data in the
group dialyzed against acetate (A versus B). Third, pre-dialysis
data were compared with post-dialysis data in the group dia-
lyzed against bicarbonate (C versus D). Finally, data obtained
following acetate hemodialysis were compared with data ob-
tained following bicarbonate hemodialysis (B versus D) to
determine if differences existed between acetate and bicarbo-
nate hemodialyses for any variable tested. These four compari-
sons were performed on the entire study population (Table 2),
on patients with normal pre-dialysis mean Vcf (Table 3), and on
patients with low pre-dialysis mean Vcf (Table 4).
No significant differences existed between mean values ob-
tained prior to acetate hemodialysis and mean values obtained
prior to bicarbonate hemodialysis (A versus C) for any variable
tested for the entire study population (Table 2), for patients with
normal pre-dialysis mean Vcf (Table 3), or for patients with low
pre-dialysis mean Vcf. All mean pre-dialysis echocardiographic
variables were normal for the 36 patients studied; however,
there was marked variation in individual echocardiographic
data. Prior to dialysis (with both bases), LVIDd was increased
in 12 (33%), LVIDS was increased in 13 (36%), interventricular
septal thickness was increased in 13 (36%), left ventricular
posterior wall thickness was increased in 12 (33%), left atrial
enlargement was present in 12 (33%), and RVID was increased
in 2 (6%) of the 36 patients studied. Mean Vcf was low in ten
subjects (28%) prior to dialysis.
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Table 2. Comparative effects of hemodialysis with acetate and bicarbonate on clinical and echocardiographic variables in 36 patientsa
Clinical or
—
Acetate HD Bicarbonate HD Level of significance (P value)
echocardiographic
variable Pre(A) Post(B) Pre(C) Post(D) A vs. C A vs. B C vs. D B vs. D
Body weight, kg 76.3 15.2 74.1 15.4 76.4 15.0 74.0 15.3 NS <0.005 <0.005 NS
Heart rate, beats/mm 73 5 84 5 72 5 84 5 NS <0.0001 <0.0001 NS
Mean blood pressure,
mm Hg 94 10 84 11 93 11 85 10 NS <0.0005 <0.0005 NS
LV internal dimension
in diastole, cm 5.5 0.5 4.9 0.6 5.5 0.5 5.0 0.6 NS <0.0005 <0.0005 NS
LV internal dimension
in systole, cm 3.7 0.8 3.3 0.7 3.7 0.7 3.0 0.7 NS <0.0005 <0.0005 <0.0005
Mean Vcf, circ/s 1.22 0.38 1.30 0.33 1.24 0.37 1.45 0.34 NS NS <0.0005 <0.001
RV internal dimension,
cm 2.0 0.3 1.9 0.3 2.0 0.2 1.9 0.3 — — — —
Left atrial size, cm 3.6 0.3 3.5 0.4 3.6 0.3 3.5 0.4 — — —
IV septal thickness, cm 1.1 0.2 1.1 0.2 1.1 0.2 1.1 0.2 — — — —
LV posterior wall
thickness, cm 1.1 0.2 1.1 0.2 1.1 0.2 1.1 0.2 — — — —
Abbreviations: HD, hemodialysis; LV, left ventricular; Vcf, velocity of circumferential fiber shortening (circumferences/s); RV, right
ventricular; IV, interventricular.
a The mean values are expressed SD.
Table 3. Comparative effects of acetate and bicarbonate hemodialysis in 26 patients with normal pre-dialysis mean Vcf
Clinical or Acetate HD Bicarbonate HD Level of significance (P value)
echocardiographic
variables Pre(A) Post(B) Pre(C) Post(D) A vs. C A vs. B C vs. D B vs. D
Body weight, kg 76.5 l3.2 74.0 15.4 76.7 15.2 74.3 15,4 NS <0.0001 <0.0001 NS
Heart rate, beats/mm 73 5 83 5 73 5 83 5 NS <0.0001 <0.0001 NS
Mean blood pressure,
mm Hg 94 12 85 12 92 13 84 9 NS <0.001 <0.001 NS
LV internal dimension
in diastole, cm 5.5 0.5 4.8 0.6 5.4 0.4 4.7 0.5 NS <0.0001 <0.0001 NS
LV internal dimension
in systole, cm 3.4 0.5 3.0 0.6 3.4 0.5 2.7 0.4 NS <0.0001 <0.0001 <0.001
Mean Vcf, circls 1.42 0.30 1.44 0.34 1.43 0.31 1.60 0.29 NS NS <0.005 <0.005
RV internal dimension,
cm 2.0 0.3 1.9 0.3 2.0 0.2 1.9 0.3 — — — —
Left atrial size, cm 3.6 0.3 3.5 0.4 3.6 0.3 3.5 3.4 — — — —
IV septal thickness, cm 1.1 0.2 1.1 0.2 1.1 0.2 1.1 0.2 — — — —
LV posterior wall
thickness, cm 1.1 0.2 1.1 0.2 1.1 0.2 1.1 0.2 — — — —
Vcf, velocity of circumferential fiber shortening (circumferences/s); RV, rightAbbreviations: HD, hemodialysis; LV, left ventricular;
ventricular; IV, interventricular.
8 The mean values are expressed SD.
Hemodialysis with either base produced a significant de-
crease in mean body weight, mean blood pressure, mean
LVIDd, mean LVIDS, a significant increase in mean heart rate,
and no significant change in left atrial size, RVID, and
interventricular septal thickness of left ventricular posterior
wall thickness both for the entire study population and for the
subgroup with normal pre-dialysis mean Vcf (Tables 2 and 3, A
versus B and C versus D). In these groups there was a
significant increase in mean Vef resulting from bicarbonate
hemodialysis but no significant difference associated with ac-
etate hemodialysis. In the ten patients with low pre-dialysis
mean Vcf, hemodialysis produced a significant decrease in
mean body weight, mean blood pressure, mean LVIDd, mean
LVIDS, a significant increase in mean heart rate, and mean Vcf
and no significant change in other variables tested.
Comparisons of post-acetate and post-bicarbonate dialysis
data (B vs. D) for clinical and echocardiographic variables
studied are shown in Tables 2 to 4. LVIDS was significantly
lower and mean Vcf was significantly higher following bi-
carbonate hemodialysis compared to acetate hemodialysis, not
only in the entire study population, but in the subgroups with
normal and low pre-dialysis mean Vef.
Discussion
In recent years increasing interest in the hemodynamic ef-
fects of hemodialysis has been witnessed. Early studies examin-
ing the effect of hemodialysis on left ventricular systolic per-
formance produced conflicting results due primarily to small
study populations and differences in patient characteristics
[15—18]. The controversy was resolved partially when it became
evident that the effect of hemodialysis on left ventricular
systolic performance was related closely to the state of left
Acetate versus bicarbonate on ventricular function 771
Table 4. Comparative effects of acetate and bicarbonate hemodialysis in ten patients with low pre-dialysis mean Vcf
Clinical or
echocardiographic
variables
Acetate HD Bicarbonate HD Level of significance (P value)
Pre(A) Post(B) Pre(C) Post(D) A vs. C A vs. B C vs. D B vs. D
Body weight, kg 75.0 13.4 72.6 13.4 75.0 13.3 72.8 12.8 NS <0.0001 <0.0001 NS
Heart rate, beats/mm 74 4 86 3 72 4 85 3 NS <0.0001 <0.0001 NS
Mean blood pressure,
mm Hg 94 8 84 9 95 9 88 10 NS <0.001 <0.001 NS
LV internal dimension
in diastole, cm 5.6 0.7 5.1 0.7 5.6 0.7 4.9 0.7 NS <0.006 <0.0001 NS
LV internal dimension
in systole, cm 4.7 0.6 4.0 0.9 4.5 0.7 3.6 0.8 NS <0.001 <0.0001 <0.01
Mean Vcf, circ/s 0.83 0.10 1.04 0.14 0.85 0.11 1.16 0.09 NS <0.01 <0.001 <0.01
RV internal dimension,
cm 1.9 0.2 1.9 0.3 1.9 0.3 1.9 0.3 — — — —
Left atrial size, cm 3.5 0.3 3.5 0.3 3.6 0.4 3.5 0.3 — — — —
IV septal thickness, cm 1.1 0.2 1.1 0.2 1.1 0.2 1.1 0.2 — — — —
LV posterior wall
thickness, cm 1.1 0.2 1.1 0.2 1.1 0.2 1.1 0.2 — — — —
Abbreviations: HD, hemodialysis; LV, left ventricular; Vcf, velocity of circumferential fiber shortening (circumferences/s); RV, right
ventricular; IV, interventricular.
a The mean values are expressed SD.
ventricular systolic function prior to dialysis [8, 9]. Prior
studies, using ejection phase indices, for example, ejection
fraction, LVFS, or mean Vcf, showed that hemodialysis pro-
duced a significant improvement in left ventricular systolic
function in patients with impaired left ventricular systolic
function prior to dialysis, but resulted in no significant change in
those with normal pre-dialysis left ventricular systolic perform-
ance [8, 9]. Because ejection phase indices may change with
alterations in preload or afterload (even when myocardial
contractility remains constant) [19—21], it remained uncertain
whether or not their improvement reflected a true increase in
myocardial contractility. Nixon et al [22] addressed this issue
by exploring the comparative effects of isolated ultrafiltration
(volume loss) and hemodialysis on left ventricular systolic
performance. They demonstrated that isolated ultrafiltration
produced a pure Frank-Starling effect, whereas hemodialysis
(with or without volume loss) produced an upward shift in the
left ventricular function curve suggesting improved left ven-
tricular contractility.
There are several plausible explanations for the improvement
in left ventricular systolic function associated with hemodialy-
sis. Decrease in afterload resulting from arteriolar dilatation and
reduction of blood pressure, or normalization of preload
achieved by volume loss may improve left ventricular function
in some cases. This hypothesis, however, does not explain the
improvement in myocardial contractility noted by Nixon et al
[22]. Chaignon et al [23] have postulated that improvement in
left ventricular function may result from alterations in calcium
and potassium homeostasis, namely an intradialytic increase in
serum calcium level and decrease in serum potassium concen-
tration. Recently, Henrich, Hunt, and Nixon [24] have shown a
positive correlation between increasing intradialytic serum cal-
cium levels and improved left ventricular function. Finally,
removal of an as yet unidentified myocardial toxin must be
considered as a possible explanation for improvement of left
ventricular performance resulting from hemodialysis. Unfortu-
nately, insufficient information presently exists to formulate a
unifying mechanism to explain the observed hemodynamic
alterations.
Controversy exists concerning the effect of hemodialysis with
acetate and bicarbonate buffers on left ventricular performance.
Kirkendol et at [2] compared the effect of bolus intravenous
infusion of various buffers (including sodium acetate and so-
dium bicarbonate) on right ventricular myocardial contractile
force in dogs. Both bases produced a depression of myocardial
contractile force, but acetate infusion resulted in a significantly
greater decrease than bicarbonate infusion. In a later study,
however, Kirkendol et al [3] was unable to demonstrate a
myocardial depressant effect of acetate. Clancy et al [4] re-
ported an initial depression of myocardial contractility follow-
ing intracoronary infusion of sodium bicarbonate in dogs,
followed by a subsequent increase in contractility after termina-
tion of the infusion. More recently, Idelson et al [5] have
demonstrated an increase in left ventricular mean Vcf in a
double-blind crossover study of nine patients using hemodialy-
sis with acetate and bicarbonate. They observed no significant
difference between the two bases in the magnitude ofimprove-
ment of left ventricular performance. Mehta et al [6] reported
similar results in a study of ten patients dialyzed against acetate
and bicarbonate. Conversely, Scandifflo et al [7] studied 12
patients and reported a significantly greater improvement in left
ventricular function (assessed by systolic time intervals) during
the tenth bicarbonate dialysis as compared to acetate
hemodialysis.
In this study, acetate hemodialysis produced a significant
improvement in left ventricular systolic function in patients
with low mean Vcf prior to dialysis, but did not result in
significant change in those with a normal pre-dialysis mean Vcf.
In contrast, bicarbonate hemodialysis produced significant im-
provement in left ventricular systolic function in patients with
both normal and low pre-dialysis mean Vcf. Moreover, mean
values obtained for these ejection phase indices after hemodi-
alysis were significantly higher in patients dialyzed with bi-
carbonate than in those dialyzed with acetate (B vs. D in Tables
2 to 4). That the study conditions were similar prior to both
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dialyses can be inferred from the lack of significant differences
between clinical and echocardiographic variables prior to ac-
etate and bicarbonate hemodialyses (A vs. C in Tables 2 to 4).
The magnitude of decrease in mean body weight and mean
blood pressure was similar during both acetate and bicarbonate
hemodialyses. This suggests that the changes in preload and
afterload were of similar magnitude and direction during dialy-
sis with either base. Thus, it appears likely that the observed
improvement in left ventricular performance did indeed reflect
an increase in myocardial contractility.
Our results clearly show a disparate response of left systolic
ventricular function between patients dialyzed against bicarbo-
nate and those dialyzed against acetate. This disparity could be
explained if bicarbonate possessed positive inotropic proper-
ties; however, previous studies suggest that this is not the case
[2—4]. Thus, it appears that sodium acetate or one of its
metabolites may have blunted the expected improvement in left
systolic ventricular function. Why acetate would be associated
with myocardial depression is uncertain. Kirkendol et al [3]
suggested that a reduced serum pool of ionized calcium result-
ing from chelation with acetate may lead to a depression of
myocardial contractility. Serum acetate levels rise markedly in
approximately 25% of patients hemodialyzed with the base [25].
The high serum levels may reflect a defect in the conversion of
acetate to bicarbonate. In such individuals, an imbalance may
occur between the supply of fixed base (bicarbonate) and its
utilization. A resultant bicarbonate deficit may produce acido-
sis, possibly leading to myocardial depression. This relatively
uncommon phenomenon, however, is not expected to produce
the global hemodynamic changes observed in this study. Fi-
nally, a decrease in arterial oxygen tension during acetate
hemodialysis [26, 27], a situation that may potentially lead to
myocardial depression, has been documented in several recent
studies.
The reasons for the disparity between our data and those of
Idelson et al [5] and Mehta et al [6] are uncertain, but may relate
to the size and composition of the study populations. Our study
population was large enough to permit separate analyses based
on pre-dialysis left ventricular systolic function. The studies of
Idelson et al [5] and Mehta et al [6] contained small patient
populations (nine and ten patients, respectively), which were
too small to analyze separately pre-dialysis left ventricular
systolic function subgroups. Moreover, it is not clear whether
or not they studied a homogenous group with respect to
pre-dialysis left ventricular systolic function. Failure to con-
sider differences in pre-dialysis left ventricular systolic per-
formance can mask important hemodynamic changes (see Ta-
bles 2 to 4).
In summary, our results show that bicarbonate hemodialysis
is associated with greater improvement in left ventricular sys-
tolic function than acetate hemodialysis. The data suggest that
acetate or one of its metabolites in some way alters myocardial
contractility in such a way as to prevent an improvement in left
ventricular performance in patients with normal pre-dialysis left
ventricular systolic function, and to blunt the expected im-
provement in those with depressed pre-dialysis left ventricular
systolic function. The clinical significance of our findings is
unclear at this time. We have not observed an episode of
congestive heart failure that could unequivocally be attributed
to acetate. Whether or not myocardial depression contributes to
the hypotensive response of some patients dialyzed against
acetate is uncertain and deserves further study.
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